CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase III Randomized Trial for Patients With De Novo AML Using Bortezomib and Sorafenib (NSC# 681239, NSC# 724772) for Patients With High Allelic Ratio FLT3/ITD
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01371981
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-06-04T12:58:48.721155+00:00
- Published At
- 2020-07-07T00:00:00+00:00
- Record Updated At
- 2026-06-02
- Results Posted At
- 2020-07-07
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Acute Myeloid Leukemia", "Leukemia Cutis", "Myeloid Neoplasm", "Myeloid Sarcoma"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-06-02"- protocolSection.identificationModule.nctId
"NCT01371981"- protocolSection.identificationModule.officialTitle
"A Phase III Randomized Trial for Patients With De Novo AML Using Bortezomib and Sorafenib (NSC# 681239, NSC# 724772) for Patients With High Allelic Ratio FLT3/ITD"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE3"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-07-07"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.